SPL Medical receives recognition in German prostate guidelines

By AuntMinnieEurope.com staff writers

June 1, 2021 -- SPL Medical has announced that its imaging MRI contrast agent, Ferrotran (Ferumoxtran), has been mentioned in the German S3-guidelines for prostate cancer for the first time.

The report was released by the Guideline Program of Oncology of the German Cancer Society and the Association of the Scientific Medical Societies in Germany.

Ferrotran was developed for the detection of lymph node metastases of prostate cancer, according to SPL Medical, a spin-off of the Radboud university medical center in Nijmegen, the Netherlands.

Copyright © 2021 AuntMinnieEurope.com

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking